Aging is not a fixed trajectory. The cellular processes that drive it — mitochondrial decline, oxidative stress, telomere attrition, hormonal shifts, and immunosenescence — are measurable, addressable, and in many cases reversible. SynergyO3's longevity protocols target these biological aging drivers with EBOO, NAD+, regenerative biologics, and physician-directed optimization.
Recognition is the first step. Dr. Volpp evaluates your complete clinical picture at your physician-led consultation.
Every patient begins with a consultation with Dr. Heather Volpp, MD. Your full clinical picture is reviewed before any protocol is designed.
SynergyO3 identifies upstream biological drivers — oxidative stress, toxin burden, immune dysregulation, pathogen load — rather than treating symptoms in isolation.
EBOO, HOCATT®, IV therapy, and regenerative biologics work as a system — addressing multiple physiological drivers simultaneously for compounding outcomes.
Aging is now understood through nine hallmarks — molecular and cellular mechanisms that progressively impair function: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication.
These hallmarks interact and accelerate each other — mitochondrial dysfunction drives oxidative damage that accelerates epigenetic aging; cellular senescence releases inflammatory mediators (SASP) that impair surrounding tissue; NAD+ depletion impairs sirtuins that regulate all nine hallmarks simultaneously.
SynergyO3's longevity approach targets the most tractable and highest-impact hallmarks: mitochondrial function (EBOO, NAD+), oxidative stress (EBOO, high-dose Vitamin C, glutathione), inflammation (EBOO, ozone), and cellular repair support (exosomes, stem cell biologics).
Epigenetic clocks (GrimAge, PhenoAge) and comprehensive biomarker panels can estimate your biological age independently of your chronological age — and track improvement over time. SynergyO3 uses objective metrics to design, execute, and refine your longevity protocol.
Book Consultation →Standard annual labs — CBC, CMP, TSH, lipids — tell you whether you're sick, not how quickly you're aging. Advanced biomarkers measuring oxidative stress, mitochondrial function, and inflammatory burden require targeted testing.
Generic supplement protocols applied without biomarker guidance address some needs while missing others. Longevity medicine requires individualization based on your specific biological aging drivers — not population-average recommendations.
Lifestyle optimization is foundational — but it does not address NAD+ depletion, mitochondrial damage already accumulated, senescent cell burden, or the vascular changes driving biological aging. Targeted interventions are required alongside lifestyle.
Extra-corporeal Blood Ozone and Oxygenation (EBOO) is a closed-circuit medical procedure that ozonates your blood outside the body — driving systemic physiological changes targeted at the specific mechanisms driving your condition.
EBOO enhances cellular oxygen utilization and stimulates mitochondrial biogenesis — directly addressing the mitochondrial dysfunction that is among the most important drivers of aging and age-related disease.
Accumulated oxidative damage is central to biological aging. EBOO activates Nrf2, upregulating the antioxidant enzyme systems that clear reactive oxygen species and protect cellular DNA, proteins, and membranes.
Arterial stiffness and endothelial dysfunction are among the most reliable predictors of biological age. EBOO's improvements in red blood cell flexibility, nitric oxide production, and vascular wall function directly address vascular aging.
Immunosenescence — the progressive dysregulation of immune function with age — is addressed by ozone therapy's immunomodulatory effects, supporting both appropriate immune activation and the clearance of senescent cells.
HOCATT® contributes uniquely to longevity protocols through multiple mechanisms: hyperthermia (heat shock protein activation, metabolic stimulation), carbonic acid vasodilation (vascular conditioning analogous to aerobic exercise), transdermal ozone (oxidative conditioning without systemic intensity), and far-infrared (mitochondrial support, detoxification). The compound effect of a single HOCATT® session spans multiple longevity pathways simultaneously — making it an exceptionally efficient addition to a comprehensive aging protocol.
Ask About HOCATT® →Ozone absorbed through skin delivers anti-inflammatory effects without the intensity of systemic EBOO.
Deep tissue heating supports detoxification, reduces musculoskeletal pain, and stimulates mitochondrial activity.
CO2 dissolved in steam causes potent vasodilation — improving peripheral circulation and oxygen delivery.
Completely non-invasive. Patients sit reclined inside the HOCATT® pod. No needles, no downtime.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, essential for mitochondrial energy production, DNA repair, and sirtuin activation — proteins that regulate all nine hallmarks of aging. NAD+ declines approximately 50% by age 50.
Biological age is an estimate of how old your body is functioning relative to your chronological age — measured through epigenetic clocks and biomarker patterns. Multiple longevity interventions have demonstrated the ability to reduce biological age by measurable amounts over 6-12 month protocols.
EBOO addresses multiple aging hallmarks simultaneously: mitochondrial function, oxidative stress, vascular aging, and immune dysregulation. It is one of the most impactful single interventions for comprehensive longevity benefit.
Exosomes are extracellular vesicles that carry genetic instructions between cells, signaling repair and regeneration. Stem cell-derived exosomes can stimulate cellular repair mechanisms that decline with age.
Yes — longevity medicine is most impactful when started before significant biological aging has accumulated. Patients in their 30s and 40s can establish optimal baselines and set a trajectory for extended healthspan.
After an initial series, quarterly EBOO is a common longevity maintenance cadence. Monthly NAD+ IV is typical. HOCATT® is often done weekly as a low-intensity ongoing protocol.
The longevity panel includes: advanced lipids, inflammatory markers, mitochondrial function proxies, complete hormonal panel, oxidative stress markers, and optionally epigenetic age testing. Dr. Volpp reviews which markers are most relevant for your profile.
Insurance is not accepted. Superbills for HSA/FSA reimbursement are available. Written pricing is provided before all services.
Before any treatment begins, Dr. Volpp reviews your complete health history, labs, and goals. Every protocol is physician-designed for your specific biology — not a template.
Book Your Consultation →(760) 450-4602 · info@synergyo3.com · Mon-Fri 9:00am-5:00pm
Insurance not accepted · HSA/FSA superbills available · Written quotes before all services